Papadopoulos G - Search Results

1

The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials.

Dahlöf C, Loder E, Diamond M, Rupnow M, Papadopoulos G, Mao L. Dahlöf C, et al. Among authors: papadopoulos g. Health Qual Life Outcomes. 2007 Oct 4;5:56. doi: 10.1186/1477-7525-5-56. Health Qual Life Outcomes. 2007. PMID: 17916258 Free PMC article. Clinical Trial.

2

Topiramate improves health-related quality of life when used to prevent migraine.

Diamond M, Dahlöf C, Papadopoulos G, Neto W, Wu SC. Diamond M, et al. Among authors: papadopoulos g. Headache. 2005 Sep;45(8):1023-30. doi: 10.1111/j.1526-4610.2005.05183.x. Headache. 2005. PMID: 16109116 Clinical Trial.

3

The impact of migraine on daily activities: effect of topiramate compared with placebo.

Silberstein SD, Loder E, Forde G, Papadopoulos G, Fairclough D, Greenberg S. Silberstein SD, et al. Among authors: papadopoulos g. Curr Med Res Opin. 2006 Jun;22(6):1021-9. doi: 10.1185/030079906X104731. Curr Med Res Opin. 2006. PMID: 16846536 Clinical Trial.

4

Migraine frequency and health utilities: findings from a multisite survey.

Brown JS, Neumann PJ, Papadopoulos G, Ruoff G, Diamond M, Menzin J. Brown JS, et al. Among authors: papadopoulos g. Value Health. 2008 Mar-Apr;11(2):315-21. doi: 10.1111/j.1524-4733.2007.00246.x. Value Health. 2008. PMID: 18380644 Free article.

5

Cost-effectiveness of migraine prevention: the case of topiramate in the UK.

Brown JS, Papadopoulos G, Neumann PJ, Price M, Friedman M, Menzin J. Brown JS, et al. Among authors: papadopoulos g. Cephalalgia. 2006 Dec;26(12):1473-82. doi: 10.1111/j.1468-2982.2006.01240.x. Cephalalgia. 2006. PMID: 17116098

6

Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatment.

Brown JS, Papadopoulos G, Neumann PJ, Friedman M, Miller JD, Menzin J. Brown JS, et al. Among authors: papadopoulos g. Headache. 2005 Sep;45(8):1012-22. doi: 10.1111/j.1526-4610.2005.05182.x. Headache. 2005. PMID: 16109115

7

Planning analyses of quality-of-life studies: a case example with migraine prophylaxis.

Fairclough DL, Gagnon D, Papadopoulos G. Fairclough DL, et al. Among authors: papadopoulos g. J Biopharm Stat. 2004 Feb;14(1):31-51. doi: 10.1081/BIP-120028505. J Biopharm Stat. 2004. PMID: 15027499

8

Mortality, length of hospitalization, and costs associated with invasive fungal infections in high-risk patients.

Menzin J, Meyers JL, Friedman M, Perfect JR, Langston AA, Danna RP, Papadopoulos G. Menzin J, et al. Among authors: papadopoulos g. Am J Health Syst Pharm. 2009 Oct 1;66(19):1711-7. doi: 10.2146/ajhp080325. Am J Health Syst Pharm. 2009. PMID: 19767376

9

The economic costs to United States hospitals of invasive fungal infections in transplant patients.

Menzin J, Meyers JL, Friedman M, Korn JR, Perfect JR, Langston AA, Danna RP, Papadopoulos G. Menzin J, et al. Among authors: papadopoulos g. Am J Infect Control. 2011 May;39(4):e15-20. doi: 10.1016/j.ajic.2010.06.009. Epub 2010 Oct 20. Am J Infect Control. 2011. PMID: 20961657

10

Measuring Alzheimer's disease progression with transition probabilities: estimates from CERAD.

Neumann PJ, Araki SS, Arcelus A, Longo A, Papadopoulos G, Kosik KS, Kuntz KM, Bhattacharjya A. Neumann PJ, et al. Among authors: papadopoulos g. Neurology. 2001 Sep 25;57(6):957-64. doi: 10.1212/wnl.57.6.957. Neurology. 2001. PMID: 11571317

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

716 results

Search Page

Filters